FDA OKs Monthly Maintenance Dose for Leqembi

 ‌

Breaking News from Newsmax Health

The FDA has approved monthly maintenance dosing for the Alzheimer's drug Leqembi, which received standard U.S. approval in 2023 after demonstrating it slowed cognitive decline in patients with the brain-wasting disease. But growth has been slow, in part because its administration is time-consuming and it requires regular MRIs and screenings. Now patients can switch to a monthly dose after having received an intravenous infusion every two weeks for 18 months. Read More Here Special: Popular Drink Linked to Alzheimer's Disease? SPONSOR   ADVERTORIAL Harvard Medical School has just revealed a disturbing link between a common drink and skyrocketing rates of Alzheimer's disease. Because this everyday drink contains shocking levels of a toxic mineral that's present in nearly 98% of Alzheimer's patients' brains… Can you guess which one it is? A) Black Coffee (Colombian Beans) B) White Wine (Chardonnay Grapes) C) Diet Soda D) Tap Water E) Beer Studies show that this toxic mineral builds in our brains over time… Killing off an important molecule that's key for keeping our precious memories intact. Which not only leads to forgetfulness and "senior moments" as you age… But it's also a shocking newly discovered root cause of Alzheimer's disease. If you think it's the drinks that contain alcohol… You might want to think again. This will surprise you! Click here to see this memory destroying drink now.   To Read More Health News go to NewsmaxHealth.com This email is never sent unsolicited. You have received this Newsmax email because you subscribed to it or someone forwarded it to you. To opt out, see the links below. TO ADVERTISE For information on advertising, please contact Newsmax Advertising Sales via email. TO SUBSCRIBE If this email has been forwarded to you and you would like to sign up, please click here. Remove your email address from our list or modify your profile. We respect your right to privacy. View our policy. This email was sent by: Newsmax.com 362 N. Haverhill Road West Palm Beach, FL 33415 USA DM745084 0105027vbai1